Quest Diagnostics (NYSE: DGX), announced on Wednesday that its board of directors declared a quarterly cash dividend of USD0.53 per share.

The dividend is payable on 29 January 2020 to shareholders of record of Quest Diagnostics common stock on 14 January 2020.

Quest Diagnostics is a provider of diagnostic information services. Derived from the world's largest database of clinical lab results, the company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviours and improve health care management.